Facial Injectable Market Size, Share & Trends Report

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jan, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-849-7
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 172

Report Overview

The global facial injectable market size was valued at USD 13.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. A growing focus on physical appearance among consumers has led to an increased demand for facial injectable in recent years. Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to the American Society of Plastic Surgeons (ASPS), in the U.S., nearly 17.7 million minimally invasive and surgical cosmetic products were performed in 2018, out of which nearly 15.9 million products were minimally invasive. Thus, the increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of such treatment options, is fuelling the market growth.

U.S. facial injectable market size, by product, 2016 - 2028 (USD Million)

The ongoing COVID-19 pandemic has increased the time spent on video calls. Known as the ‘Zoom Boom’, several adults are becoming more aware of their appearance. This has increased demand for cosmetic surgeries, with Botox being one of the most popular products preferred. Patients are also opting for cosmetic surgeries owing to the ease of recovery while staying at home. Thus, the market for facial injectable has witnessed a spike during the pandemic.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked 1st in terms of non-surgical products performed at the global level. Of these, injectables such as botulinum toxin and hyaluronic acid were among the most popular products performed. The country is backed by advanced treatment options and has the highest number of surgeons at the global level, with over 7,000 plastic surgeons as of 2019. These factors support market growth.

In June 2020, Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), received the FDA approval of JUVÉDERM® VOLUMA™ XC for the augmentation of the chin region in adults over the age of 21. Apart from this, in 2019, the FDA approved, Jeuveau, which is similar to Botox, however, available at a lower cost compared to Botox. The product is found to be effective in reducing wrinkles.

Product Insights

Botulinum toxin type A led the market in 2020 with a share of 55.1%. Middle-aged women are increasingly opting for fillers and injectables, including the popular Botox to reverse the signs of aging. Based on product, the market for facial injectable has been segmented into collagen, botulinum toxin type A, hyaluronic acid (HA), calcium hydroxylapatite (CaHA), and polymer fillers.

Hyaluronic acid is projected to expand at the fastest CAGR of 9.3% from 2021 to 2028. It is known for its ability to store moisture in the skin, thus making the skin look healthier. HA has a moisture-binding characteristic that helps enhance and maintain the vital moisture responsible for the plumpness of the facial skin.

Application Insights

Based on application, the market for facial injectable has been segmented into aesthetics and therapeutics. The aesthetics segment dominated the market in 2020 with a share of 70.3% and is expected to maintain its lead during the forecast period owing to the increasing use of facial injectables for aesthetic procedures, such as facial lines, wrinkles on the face, and lip lines. The growing interest in physical appearance, along with an increase in disposable income among the middle-class population in developing countries, such as India, is expected to boost demand for facial injectable for aesthetic purposes in the coming years.

Regional Insights

North America dominated the market in 2020 with a share of more than 41.0%. According to the American Society of Plastic Surgeons (ASPS), the growth in the rates of cosmetic surgery products from the year 2000 to 2018 was compared. It was observed that the use of Botox injections increased by 845%. Thus, North America is expected to be a key revenue generator for facial injectable in the coming years.

Global facial injectable market share, by region, 2020 (%)

Asia Pacific is projected to expand at the highest CAGR of 10.0% from 2021 to 2028. The region is backed by countries such as India, Australia, and South Korea. Growing focus on the physical appearance in these developing countries is expected to play a key role in the demand for facial injectable treatment. India is projected to witness the fastest growth during the forecast period.

Key Companies & Market Share Insights

Key players are focusing on growth strategies, such as enhancements in the existing technologies, geographical expansion, product launches, and product approvals. Recently, in 2019, one of the key players, Allergan had launched a TV ad campaign for its brand, Botox Cosmetic for millennials. According to the American Academy of Facial Plastic and Reconstructive Surgery, in the past five years, Botox injections have increased by 22% among 22- to 37-year-olds, focusing on which the product is being launched by the company. Some prominent players in the global facial injectable market include:

  • ALLERGAN

  • Ipse

  • Merz Pharma

  • Suneva Medical, Inc.

  • Medytox, Inc.

  • Sinclair Pharma

  • Bloomage BioTechnology Corporation Limited

  • Anika Therapeutics, Inc.

  • Prollenium Medical Technologies Inc.

  • Galderma S.A.

Facial Injectable Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 15.3 billion

Revenue forecast in 2028

USD 27.7 billion

Growth Rate

CAGR of 8.8% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Switzerland; Netherlands; Belgium; China; India; Japan; Australia; South Korea; Thailand; Malaysia; Singapore; Indonesia; Philippines; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Turkey

Key companies profiled

ALLERGAN; Ipse; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; Galderma S.A.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global facial injectable market report on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Collagen

    • Hyaluronic Acid (HA)

    • Botulinum Toxin Type A

    • Calcium Hydroxylapatite (CaHA)

    • Polymer Fillers

      • Polymethylmethacrylate beads (PMMA Microspheres)

      • Poly-L-Lactic Acid (PLLA)

  •  Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Aesthetics

    • Therapeutics

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Switzerland

      • Netherlands

      • Belgium

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

      • Malaysia

      • Singapore

      • Indonesia

      • Philippines

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Israel

      • Turkey

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities